Given the semi-quantitative nature of immunohistochemistry and the fact that KLKs are secreted proteins, to see a significant difference in the cellular levels between normal OSE and ovarian cancer would require not only changes in KLK protein production, but also a significant change in the rate of kallikrein exocytosis. The gene discussed is KLK4; the disease is ovarian carcinoma.